Moneycontrol
Close Ad
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Mangalam Drugs & Organics

BSE: 532637|NSE: MANGALAM|ISIN: INE584F01014|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 11, 16:00
184.80
-1.8 (-0.96%)
VOLUME 27,698
LIVE
NSE
Dec 11, 15:57
183.55
-2.95 (-1.58%)
VOLUME 105,020
Announcements on Mangalam Drugs

8th-Dec-2017 17:33Source: BSE

Mangalam Drugs & Organics- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Rasbihari Trading & Investment Pvt Ltd

7th-Dec-2017 12:31Source: BSE

Mangalam Drugs & Organics- Board Meeting On 12Th December, 2017.

This is to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 12th December, 2017 inter-alia, to consider and declare the interim dividend for the...

7th-Dec-2017 12:31Source: BSE

Mangalam Drugs & Organics- Board to consider Interim Dividend

Mangalam Drugs & Organics Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on December 12, 2017, inter alia, to consider and declare the interim d...

20th-Nov-2017 13:40Source: BSE

Mangalam Drugs & Organics- Appointment of Director

Change in Directorate

20th-Nov-2017 13:37Source: BSE

Mangalam Drugs & Organics- Outcome of Board Meeting

Intimation of Outcome of Board Meeting dated 20th November, 2017. At 13:28 hrs Mangalam Drugs & Organics was quoting at Rs 158.70, up Rs 6.50, or 4.27 percent. The share touched its 52-week high...

20th-Nov-2017 13:28Source: BSE

Mangalam Drugs & Organics- Financial Results For September 30, 2017.

Unaudited Financial Results for the quarter and half year ended 30th September, 2017 along with Limited Review Report and the Statement of Assets & Liabilities of the said period in the prescribed for...

9th-Nov-2017 13:42Source: BSE

Mangalam Drugs & Organics- Board Meeting On November 20, 2017.

In terms of Regulation 29 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to ...

18th-Oct-2017 12:02Source: BSE

Mangalam Drugs & Organics- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Kishoriju Trading & Investment Pvt Ltd

16th-Oct-2017 15:21Source: BSE

Mangalam Drugs & Organics- Certificate Under Regulation 40 (10) Of SEBI (LODR) Regulations 2015 For Half Year Ended 30Th September, 2017.

Please find enclosed herewith the Certificate Under Regulation 40(9) / 40(10) of Securities and Exchange Board of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 for the half...

13th-Oct-2017 16:46Source: BSE

Mangalam Drugs & Organics- Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Rasbihari Trading & Investment Pvt...

1 2 3 4 5 Next >>
Board Meeting (Mangalam Drugs)

Meeting Date

Remark

2017-12-12

Interim Dividend

Quick Links for Mangalam Drugs & Organics
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.